Cannabinoids for Anxiety and Sleep Disturbances: A Scoping Review.

ABSTRACT:

Background

At least 60% of individuals with anxiety disorders report sleep disturbances, which might be explained by shared physiological mechanisms, including cortisol dysregulation and executive function skills disruption. The scientific literature regarding medical cannabis as a potential therapeutic candidate for these conditions increased about 15 times in the last 10 years. However, assessments of cannabinoid exposure, anxiety, and sleep are inconsistent across studies, and the quality of the evidence is not often assessed.

Summary

We conducted a scoping review to examine the current knowledge on cannabinoid use for anxiety and sleep disturbances. We applied our search strategy to PubMed, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Con

SUBMITTER: Perez JG 

PROVIDER: S-EPMC12695116 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature